Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized open-label study of switching to Trizivir in HIV-1 patients with hepatitis C-related liver cirrhosis
2004-004060-70Phase 3Active
- Sponsor
- Juan Gonzalez GarcÃa
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of abacavir in human immunodeficiency virus infection (HIV), Cirrhosis and hepatitis C virus infection (2 arms), sponsored by Juan Gonzalez GarcÃa. Primary endpoint: Proportion of adverse events and/or withdrawals due to Trizivir treatment. Started May 2005; status: active.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)Cirrhosishepatitis C virus infection
Beyond the preview
Go deeper on 2004-004060-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004060-70.